Advertisement

Neonatology pp 1773-1784 | Cite as

Neonatal Septic Shock

  • Rajesh K. Aneja
  • Ruby V. Aneja
  • Misty Good
  • Joseph A. Carcillo
Reference work entry

Abstract

Neonatal sepsis continues to be a major health problem in the world. Over the last decade, there has been an overall decrease in the incidence of neonatal sepsis. The institution of intrapartum Group B Streptococcus (GBS) prophylaxis has also led to a decrease in GBS early-onset disease. Early recognition and treatment of sepsis is essential to halt its progression to severe sepsis and septic shock. In this chapter, we compare the essential differences between the hemodynamic response to shock in neonates and older children. We also discuss various factors that make diagnosis and treatment of neonatal shock challenging. The American College of Critical Care Medicine recently published an update to their clinical practice parameters for the management of septic shock. We summarize these guidelines and briefly review thrombocytopenia-associated multiple organ failure in sepsis.

References

  1. (2009) Trends in perinatal group B streptococcal disease – United States, 2000–2006. MMWR Morb Mortal Wkly Rep 58:109–112Google Scholar
  2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310CrossRefGoogle Scholar
  3. Baker CF, Barks JD, Engmann C, Vazquez DM, Neal CR Jr, Schumacher RE, Bhatt-Mehta V (2008) Hydrocortisone administration for the treatment of refractory hypotension in critically ill newborns. J Perinatol 28:412–419CrossRefGoogle Scholar
  4. Banerjea MC, Speer CP (2002) The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis. Semin Neonatol 7:335–349CrossRefGoogle Scholar
  5. Bedford Russell AR, Emmerson AJ, Wilkinson N, Chant T, Sweet DG, Halliday HL, Holland B, Davies EG (2001) A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed 84:F172–F176CrossRefGoogle Scholar
  6. Benjamin DK Jr, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH (2003) Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 112:543–547CrossRefGoogle Scholar
  7. Bilgin K, Yaramis A, Haspolat K, Tas MA, Gunbey S, Derman O (2001) A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia. Pediatrics 107:36–41CrossRefGoogle Scholar
  8. Brian Smith P, Steinbach WJ, Benjamin DK Jr (2005) Invasive Candida infections in the neonate. Drug Resist Updat 8:147–162CrossRefGoogle Scholar
  9. Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688CrossRefGoogle Scholar
  10. Carcillo JA, Fields AI (2002) Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med 30:1365–1378CrossRefGoogle Scholar
  11. Carcillo JA, Doughty L, Kofos D, Frye RF, Kaplan SS, Sasser H, Burckart GJ (2003) Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med 29:980–984CrossRefGoogle Scholar
  12. Carr R, Brocklehurst P, Dore CJ, Modi N (2009) Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet 373:226–233CrossRefGoogle Scholar
  13. Cawley MJ, Briggs M, Haith LR Jr, Reilly KJ, Guilday RE, Braxton GR, Patton ML (1999) Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review. Pharmacotherapy 19:1094–1098CrossRefGoogle Scholar
  14. Chapman RL (2003) Candida infections in the neonate. Curr Opin Pediatr 15:97–102CrossRefGoogle Scholar
  15. Cooke RWI (1992) Report of working group of the British Association of Perinatal Medicine and Neonatal Nurses Association on categories of babies requiring neonatal care. Arch Dis Child 67:868–869Google Scholar
  16. Dempsey EM, Barrington KJ (2006) Diagnostic criteria and therapeutic interventions for the hypotensive very low birth weight infant. J Perinatol 26:677–681CrossRefGoogle Scholar
  17. Dempsey EM, Barrington KJ (2009) Evaluation and treatment of hypotension in the preterm infant. Clin Perinatol 36:75–85CrossRefGoogle Scholar
  18. Despond O, Proulx F, Carcillo JA, Lacroix J (2001) Pediatric sepsis and multiple organ dysfunction syndrome. Curr Opin Pediatr 13:247–253CrossRefGoogle Scholar
  19. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR et al (2007) Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196(147):e141–e148Google Scholar
  20. Goldman S, Ellis R, Dhar V, Cairo MS (1998) Rationale and potential use of cytokines in the prevention and treatment of neonatal sepsis. Clin Perinatol 25:699–710CrossRefGoogle Scholar
  21. Goldstein B, Nadel S, Peters M, Barton R, Machado F, Levy H, Haney DJ, Utterback B, Williams MD, Giroir BP (2006) ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis. Pediatr Crit Care Med 7:200–211CrossRefGoogle Scholar
  22. Graves GR, Rhodes PG (1984) Tachycardia as a sign of early onset neonatal sepsis. Pediatr Infect Dis 3:404–406CrossRefGoogle Scholar
  23. Gurevich P, Ben-Hur H, Czernobilsky B, Nyska A, Zuckerman A, Zusman I (1995) Pathology of lymphoid organs in low birth weight infants subjected to antigen-related diseases: a morphological and morphometric study. Pathology 27:121–126CrossRefGoogle Scholar
  24. Hallwirth U, Pomberger G, Zaknun D, Szepfalusi Z, Horcher E, Pollak A, Roth E, Spittler A (2002) Monocyte phagocytosis as a reliable parameter for predicting early-onset sepsis in very low birthweight infants. Early Hum Dev 67:1–9CrossRefGoogle Scholar
  25. Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, Orr RA (2003) Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics 112:793–799CrossRefGoogle Scholar
  26. Haque K, Mohan P (2003) Pentoxifylline for neonatal sepsis. Cochrane Database Syst Rev CD004205Google Scholar
  27. Hartman M, Clermont G, Angus D, Watson R (2008) Pediatric severe sepsis in the US: 1995 vs. 2005. Crit Care Med 36:A76Google Scholar
  28. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG et al (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166:6952–6963CrossRefGoogle Scholar
  29. Janota J, Stranak Z, Belohlavkova S, Mudra K, Simak J (2001) Postnatal increase of procalcitonin in premature newborns is enhanced by chorioamnionitis and neonatal sepsis. Eur J Clin Invest 31:978–983CrossRefGoogle Scholar
  30. Jenson HB, Pollock BH (1998) The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis. Semin Perinatol 22:50–63CrossRefGoogle Scholar
  31. Kashlan F, Smulian J, Shen-Schwarz S, Anwar M, Hiatt M, Hegyi T (2000) Umbilical vein interleukin 6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. Pediatr Infect Dis J 19:238–243CrossRefGoogle Scholar
  32. Kaufman D (2004) Fungal infection in the very low birthweight infant. Curr Opin Infect Dis 17:253–259CrossRefGoogle Scholar
  33. Kreymann KG, de Heer G, Nierhaus A, Kluge S (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35:2677–2685PubMedGoogle Scholar
  34. Krueger M, Nauck MS, Sang S, Hentschel R, Wieland H, Berner R (2001) Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate 80:118–123CrossRefGoogle Scholar
  35. Kucukoduk S, Sezer T, Yildiran A, Albayrak D (2002) Randomized, double-blinded, placebo-controlled trial of early administration of recombinant human granulocyte colony-stimulating factor to non-neutropenic preterm newborns between 33 and 36 weeks with presumed sepsis. Scand J Infect Dis 34:893–897CrossRefGoogle Scholar
  36. Kuster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, Zbojan J, Geiger R, Lipowsky G, Simbruner G (1998) Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 352:1271–1277CrossRefGoogle Scholar
  37. La Gamma EF, De Castro MH (2002) What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit? Acta Paediatr Suppl 91:109–116CrossRefGoogle Scholar
  38. Miall-Allen VM, de Vries LS, Whitelaw AG (1987) Mean arterial blood pressure and neonatal cerebral lesions. Arch Dis Child 62:1068–1069CrossRefGoogle Scholar
  39. Moller JC, Nelskamp I, Jensen R, Reiss I, Kohl M, Gatermann S, Iven H, Gortner L (1997) Comparison of vancomycin and teicoplanin for prophylaxis of sepsis with coagulase negative staphylococci (CONS) in very low birth weight (VLBW) infants. J Perinat Med 25:361–367CrossRefGoogle Scholar
  40. Nandyal RR (2008) Update on group B streptococcal infections: perinatal and neonatal periods. J Perinat Neonatal Nurs 22:230–237CrossRefGoogle Scholar
  41. Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, Wong RP, Cheung KL (1997) Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 77:F221–F227CrossRefGoogle Scholar
  42. Ng PC, Lee CH, Bnur FL, Chan IH, Lee AW, Wong E, Chan HB, Lam CW, Lee BS, Fok TF (2006) A double-blind, randomized, controlled study of a “stress dose” of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics 117:367–375CrossRefGoogle Scholar
  43. Nguyen T, Hall M, Han Y, Fiedor M, Hasset A, Lopez-Plaza I, Watson S, Lum L, Carcillo JA (2001) Microvascular thrombosis in pediatric multiple organ failure: is it a therapeutic target? Pediatr Crit Care Med 2:187–196CrossRefGoogle Scholar
  44. Pammi M, Haque KN (2015) Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 3:CD004205Google Scholar
  45. Parravicini E, van de Ven C, Anderson L, Cairo MS (2002) Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis. Transfus Med Rev 16:11–24CrossRefGoogle Scholar
  46. Paternoster DM, Laureti E (1996) Persistent foetal tachycardia as an early marker of chorion-amnionitis. Description of a clinical case. Minerva Ginecol 48:371–374PubMedGoogle Scholar
  47. Perry EH, Bada HS, Ray JD, Korones SB, Arheart K, Magill HL (1990) Blood pressure increases, birth weight-dependent stability boundary, and intraventricular hemorrhage. Pediatrics 85:727–732PubMedGoogle Scholar
  48. Rogers BB, Alexander JM, Head J, McIntire D, Leveno KJ (2002) Umbilical vein interleukin-6 levels correlate with the severity of placental inflammation and gestational age. Hum Pathol 33:335–340CrossRefGoogle Scholar
  49. Romagnoli C, Frezza S, Cingolani A, De Luca A, Puopolo M, De Carolis MP, Vento G, Antinori A, Tortorolo G (2001) Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 160:345–350CrossRefGoogle Scholar
  50. Roman J, Velasco F, Fernandez F, Fernandez M, Villalba R, Rubio V, Torres A (1992) Protein C, protein S and C4b-binding protein in neonatal severe infection and septic shock. J Perinat Med 20:111–116CrossRefGoogle Scholar
  51. Roman J, Velasco F, Fernandez F, Fernandez M, Villalba R, Rubio V, Vicente A, Torres A (1993) Coagulation, fibrinolytic and kallikrein systems in neonates with uncomplicated sepsis and septic shock. Haemostasis 23:142–148PubMedGoogle Scholar
  52. Sadana S, Mathur NB, Thakur A (1997) Exchange transfusion in septic neonates with sclerema: effect on immunoglobulin and complement levels. Indian Pediatr 34:20–25PubMedGoogle Scholar
  53. Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346:305–310CrossRefGoogle Scholar
  54. Schroder CH, Severijnen RS, Potting CM (1992) Continuous arteriovenous hemofiltration (CAVH) in a premature newborn as treatment of overhydration and hyperkalemia due to sepsis. Eur J Pediatr Surg 2:368–369CrossRefGoogle Scholar
  55. Silveira RC, Procianoy RS (1999) Evaluation of interleukin-6, tumour necrosis factor-alpha and interleukin-1beta for early diagnosis of neonatal sepsis. Acta Paediatr 88:647–650CrossRefGoogle Scholar
  56. Smith OP, White B, Vaughan D, Rafferty M, Claffey L, Lyons B, Casey W (1997) Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 350:1590–1593CrossRefGoogle Scholar
  57. Smulian JC, Vintzileos AM, Lai YL, Santiago J, Shen-Schwarz S, Campbell WA (1999) Maternal chorioamnionitis and umbilical vein interleukin-6 levels for identifying early neonatal sepsis. J Matern Fetal Med 8:88–94PubMedGoogle Scholar
  58. Soliman AT, Taman KH, Rizk MM, Nasr IS, Alrimawy H, Hamido MS (2004) Circulating adrenocorticotropic hormone (ACTH) and cortisol concentrations in normal, appropriate-for-gestational-age newborns versus those with sepsis and respiratory distress: cortisol response to low-dose and standard-dose ACTH tests. Metabolism 53:209–214CrossRefGoogle Scholar
  59. Stiehm ER (1997) Human intravenous immunoglobulin in primary and secondary antibody deficiencies. Pediatr Infect Dis J 16:696–707CrossRefGoogle Scholar
  60. Stoll BJ, Holman RC, Schuchat A (1998) Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics 102:e18CrossRefGoogle Scholar
  61. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE et al (2002a) Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 347:240–247CrossRefGoogle Scholar
  62. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE et al (2002b) Late-onset sepsis in very low birth weight neonates: the experience of the NICHD neonatal research network. Pediatrics 110:285–291CrossRefGoogle Scholar
  63. The Acute Respiratory Distress Syndrome, N (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRefGoogle Scholar
  64. Togari H, Mikawa M, Iwanaga T, Matsumoto N, Kawase A, Hagisawa M, Ogino T, Goto R, Watanabe I, Kito H et al (1983) Endotoxin clearance by exchange blood transfusion in septic shock neonates. Acta Paediatr Scand 72:87–91CrossRefGoogle Scholar
  65. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadullah K, Muller JM, Docke WD, Kox WJ (1996) Monocyte deactivation – rationale for a new therapeutic strategy in sepsis. Intensive Care Med 22(Suppl 4):S474–S481CrossRefGoogle Scholar
  66. Wardle SP, Yoxall CW, Weindling AM (1999) Peripheral oxygenation in hypotensive preterm babies. Pediatr Res 45:343–349CrossRefGoogle Scholar
  67. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC (2003) The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 167:695–701CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Rajesh K. Aneja
    • 1
  • Ruby V. Aneja
    • 2
  • Misty Good
    • 3
  • Joseph A. Carcillo
    • 1
  1. 1.Departments of Critical Care Medicine and PediatricsUniversity of Pittsburgh School of Medicine, Children’s Hospital of PittsburghPittsburghUSA
  2. 2.Division of NeonatologyTemple University, West Penn HospitalPittsburghUSA
  3. 3.Division of NeonatologyUniversity of Pittsburgh School of Medicine, Children’s Hospital of PittsburghPittsburghUSA

Personalised recommendations